申请人:Hahn Hoh-Gyu
公开号:US20140171402A1
公开(公告)日:2014-06-19
The present invention relates to an azetidine derivative or a pharmaceutically acceptable salt thereof, and an antidepressant agent or a composition for the prevention or treatment of psychiatric disorders including the same. The azetidine derivative is useful as a triple reuptake inhibitor capable of inhibiting reuptake of the neurotransmitters, dopamine, serotonin, and norepinephrine at the same time.
本发明涉及一种氮杂环丙烷衍生物或其药用可接受盐,以及一种抗抑郁剂或用于预防或治疗包括其在内的精神障碍的组合物。该氮杂环丙烷衍生物可用作三重摄取抑制剂,能够同时抑制神经递质多巴胺、5-羟色胺和去甲肾上腺素的摄取。